We decode the language of life to unlock personalised health solutions.
We make the invisible, visible
We make the universal, personal
We make the theoretical, practical
We make the impossible, possible
Accelerating drug discovery
The life sciences sector is under pressure to accelerate drug discovery and develop personalised, preventative treatments more quickly and more effectively. Currently, 95% of drugs entering clinical trials fail, pushing the average total cost of bringing a new drug to market beyond $2.3 billion.
But this can now change. Drugs supported by human genetic evidence are 2.6x more likely to succeed in clinical trials. Life sciences companies need a trusted partner to provide high quality genomic insights, accelerate clinical trials and identify the best clinical pathways with the right patients. With Genomics’ genotype-phenotype comprehensive database, seen as the most powerful in the world, we unlock smarter R&D and more targeted medicine for patients.
Advancing global health
Through Health & Wellness, we are leading the new area of genomic prevention—a paradigm-changing approach to personalised healthcare. Using advanced, reliable risk estimates for common diseases, we deliver targeted screening to prevent disease or catch it early when outcomes remain favorable.
Our population health management services and clinical decision support tools bring genetic insights to healthcare providers worldwide, ensuring personalized risk prediction reaches those who need it most.
Accelerating drug discovery
Through our Life Sciences division, we partner with leading pharmaceutical companies to incorporate deep genetic insights into drug research and development.Backed by one of the world's leading investors in life sciences, the Genomics team operates as a multi-disciplinary group of over 100 scientists, engineers and deployment specialists.
Our expertise in turning world-leading science into powerful applications continues to accelerate healthcare breakthroughs in Oxford, Amsterdam, Cambridge (UK), Cambridge (MA), and Boston (US).
Our investors
From Oxford to the world
What began with four visionaries at the University of Oxford has grown into a global force of over 140 experts. Our scientists, engineers, and innovators span three continents but share one mission: transforming how the world understands and uses genomics. From our labs in Oxford and Cambridge to our offices in Boston, we're building bridges between cutting-edge research and real-world healthcare solutions. This is precision medicine without borders—powered by diverse perspectives, united by purpose.
